guidelines:
  1: Mumtaz_score_for_readmission_in_cirrhosis.v1
test_cases:
- id: Total score 49
  input:
    1:
      gt0004|Primary payer: 5|local::at0013|Medicaid|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 5|local::at0019|Yes|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 67.3%
      gt0094|Mumtaz score: 49,1

- id: Total score 48
  input:
    1:
      gt0004|Primary payer: 4|local::at0011|Medicare|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 5|local::at0019|Yes|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 66.2%
      gt0094|Mumtaz score: 48,1

- id: Total score 47
  input:
    1:
      gt0004|Primary payer: 5|local::at0013|Medicaid|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 5|local::at0019|Yes|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 65.1%
      gt0094|Mumtaz score: 47,1

- id: Total score 46
  input:
    1:
      gt0004|Primary payer: 4|local::at0011|Medicare|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 5|local::at0019|Yes|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 63.9%
      gt0094|Mumtaz score: 46,1

- id: Total score 45
  input:
    1:
      gt0004|Primary payer: 5|local::at0013|Medicaid|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 5|local::at0019|Yes|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 62.8%
      gt0094|Mumtaz score: 45,1

- id: Total score 44
  input:
    1:
      gt0004|Primary payer: 4|local::at0011|Medicare|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 5|local::at0019|Yes|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 61.6%
      gt0094|Mumtaz score: 44,1

- id: Total score 43
  input:
    1:
      gt0004|Primary payer: 5|local::at0013|Medicaid|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 5|local::at0019|Yes|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 60.4%
      gt0094|Mumtaz score: 43,1

- id: Total score 42
  input:
    1:
      gt0004|Primary payer: 5|local::at0013|Medicaid|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 5|local::at0019|Yes|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 59.2%
      gt0094|Mumtaz score: 42,1

- id: Total score 41
  input:
    1:
      gt0004|Primary payer: 5|local::at0013|Medicaid|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 5|local::at0019|Yes|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 58.0%
      gt0094|Mumtaz score: 41,1

- id: Total score 40
  input:
    1:
      gt0004|Primary payer: 5|local::at0013|Medicaid|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 56.8%
      gt0094|Mumtaz score: 40,1

- id: Total score 39
  input:
    1:
      gt0004|Primary payer: -3|local::at0010|Self-pay|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 5|local::at0019|Yes|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 55.5%
      gt0094|Mumtaz score: 39,1

- id: Total score 38
  input:
    1:
      gt0004|Primary payer: -1|local::at0012|No change or other|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 5|local::at0019|Yes|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 4|local::at0006|40-65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 54.3%
      gt0094|Mumtaz score: 38,1

- id: Total score 37
  input:
    1:
      gt0004|Primary payer: 5|local::at0013|Medicaid|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 53.1%
      gt0094|Mumtaz score: 37,1


- id: Total score 36
  input:
    1:
      gt0004|Primary payer: 0|local::at0009|Private insurance|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 51.8%
      gt0094|Mumtaz score: 36,1

- id: Total score 35
  input:
    1:
      gt0004|Primary payer: 4|local::at0011|Medicare|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 50.6%
      gt0094|Mumtaz score: 35,1

- id: Total score 34
  input:
    1:
      gt0004|Primary payer: 5|local::at0013|Medicaid|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 5|local::at0019|Yes|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 1|local::at0041|Home health care|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 49.3%
      gt0094|Mumtaz score: 34,1

- id: Total score 33
  input:
    1:
      gt0004|Primary payer: 4|local::at0011|Medicare|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 5|local::at0019|Yes|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 1|local::at0041|Home health care|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 48.1%
      gt0094|Mumtaz score: 33,1

- id: Total score 32
  input:
    1:
      gt0004|Primary payer: 4|local::at0011|Medicare|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 5|local::at0019|Yes|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 4|local::at0006|40-65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 46.8%
      gt0094|Mumtaz score: 32,1

- id: Total score 31
  input:
    1:
      gt0004|Primary payer: 5|local::at0013|Medicaid|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 5|local::at0019|Yes|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 0|local::at0005|≥65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 45.6%
      gt0094|Mumtaz score: 31,1

- id: Total score 30
  input:
    1:
      gt0004|Primary payer: 5|local::at0013|Medicaid|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 0|local::at0005|≥65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 44.3%
      gt0094|Mumtaz score: 30,1

- id: Total score 29
  input:
    1:
      gt0004|Primary payer: 4|local::at0011|Medicare|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 0|local::at0005|≥65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 43.1%
      gt0094|Mumtaz score: 29,1

- id: Total score 28
  input:
    1:
      gt0004|Primary payer: 0|local::at0009|Private insurance|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 0|local::at0005|≥65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 41.9%
      gt0094|Mumtaz score: 28,1

- id: Total score 27
  input:
    1:
      gt0004|Primary payer: 0|local::at0009|Private insurance|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 0|local::at0005|≥65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 40.7%
      gt0094|Mumtaz score: 27,1

- id: Total score 26
  input:
    1:
      gt0004|Primary payer: -1|local::at0012|No change or other|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 0|local::at0005|≥65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 39.5%
      gt0094|Mumtaz score: 26,1

- id: Total score 25
  input:
    1:
      gt0004|Primary payer: -1|local::at0012|No change or other|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 0|local::at0005|≥65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 38.3%
      gt0094|Mumtaz score: 25,1

- id: Total score 24
  input:
    1:
      gt0004|Primary payer: 0|local::at0009|Private insurance|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 10|local::at0042|Against medical advice|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 0|local::at0005|≥65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 37.1%
      gt0094|Mumtaz score: 24,1

- id: Total score 23
  input:
    1:
      gt0004|Primary payer: 0|local::at0009|Private insurance|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 1|local::at0041|Home health care|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 0|local::at0005|≥65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 36.0%
      gt0094|Mumtaz score: 23,1

- id: Total score 22
  input:
    1:
      gt0004|Primary payer: 0|local::at0009|Private insurance|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 5|local::at0019|Yes|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 1|local::at0041|Home health care|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 0|local::at0005|≥65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 34.8%
      gt0094|Mumtaz score: 22,1

- id: Total score 21
  input:
    1:
      gt0004|Primary payer: 0|local::at0009|Private insurance|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 1|local::at0041|Home health care|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 0|local::at0005|≥65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 33.7%
      gt0094|Mumtaz score: 21,1

- id: Total score 20
  input:
    1:
      gt0004|Primary payer: -3|local::at0010|Self-pay|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 5|local::at0019|Yes|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: 0|local::at0018|No|
      gt0018|Disposition: 0|local::at0039|Routine|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 0|local::at0005|≥65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 32.6%
      gt0094|Mumtaz score: 20,1

- id: Total score 19
  input:
    1:
      gt0004|Primary payer: -3|local::at0010|Self-pay|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 5|local::at0019|Yes|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 1|local::at0041|Home health care|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 31.5%
      gt0094|Mumtaz score: 19,1


- id: Total score 18
  input:
    1:
      gt0004|Primary payer: -3|local::at0010|Self-pay|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 5|local::at0019|Yes|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 0|local::at0039|Routine|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 30.4%
      gt0094|Mumtaz score: 18,1

- id: Total score 17
  input:
    1:
      gt0004|Primary payer: -1|local::at0012|No change or other|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 0|local::at0039|Routine|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 29.4%
      gt0094|Mumtaz score: 17,1

- id: Total score 16
  input:
    1:
      gt0004|Primary payer: -1|local::at0012|No change or other|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 0|local::at0039|Routine|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 28.3%
      gt0094|Mumtaz score: 16,1

- id: Total score 15
  input:
    1:
      gt0004|Primary payer: 0|local::at0009|Private insurance|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 0|local::at0039|Routine|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 27.3%
      gt0094|Mumtaz score: 15,1

- id: Total score 14
  input:
    1:
      gt0004|Primary payer: -1|local::at0012|No change or other|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 0|local::at0039|Routine|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 26.4%
      gt0094|Mumtaz score: 14,1

- id: Total score 13
  input:
    1:
      gt0004|Primary payer: -3|local::at0010|Self-pay|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 5|local::at0019|Yes|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 0|local::at0039|Routine|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 25.4%
      gt0094|Mumtaz score: 13,1

- id: Total score 12
  input:
    1:
      gt0004|Primary payer: -3|local::at0010|Self-pay|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 0|local::at0039|Routine|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 7|local::at0019|Yes|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 24.5%
      gt0094|Mumtaz score: 12,1

- id: Total score 11
  input:
    1:
      gt0004|Primary payer: -3|local::at0010|Self-pay|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 1|local::at0041|Home health care|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 23.6%
      gt0094|Mumtaz score: 11,1

- id: Total score 10
  input:
    1:
      gt0004|Primary payer: -1|local::at0012|No change or other|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 1|local::at0041|Home health care|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 22.7%
      gt0094|Mumtaz score: 10,1

- id: Total score 9
  input:
    1:
      gt0004|Primary payer: -1|local::at0012|No change or other|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 1|local::at0041|Home health care|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 21.8%
      gt0094|Mumtaz score: 9,1

- id: Total score 8
  input:
    1:
      gt0004|Primary payer: -1|local::at0012|No change or other|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 1|local::at0041|Home health care|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 21.0%
      gt0094|Mumtaz score: 8,1

- id: Total score 7
  input:
    1:
      gt0004|Primary payer: 0|local::at0009|Private insurance|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 1|local::at0041|Home health care|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 20.1%
      gt0094|Mumtaz score: 7,1

- id: Total score 6
  input:
    1:
      gt0004|Primary payer: -1|local::at0012|No change or other|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 4|local::at0019|Yes|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 1|local::at0041|Home health care|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 19.4%
      gt0094|Mumtaz score: 6,1

- id: Total score 5
  input:
    1:
      gt0004|Primary payer: -3|local::at0010|Self-pay|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 1|local::at0041|Home health care|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 18.6%
      gt0094|Mumtaz score: 5,1

- id: Total score 4
  input:
    1:
      gt0004|Primary payer: -3|local::at0010|Self-pay|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 0|local::at0039|Routine|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 17.8%
      gt0094|Mumtaz score: 4,1

- id: Total score 3
  input:
    1:
      gt0004|Primary payer: -3|local::at0010|Self-pay|
      gt0005|Elixhauser Comorbidity Index: 2|local::at0016|≥3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: -1|local::at0040|Transfer|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 17.1%
      gt0094|Mumtaz score: 3,1

- id: Total score 2
  input:
    1:
      gt0004|Primary payer: 0|local::at0009|Private insurance|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: -1|local::at0040|Transfer|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 7|local::at0007|18-39|
  expected_output:
    1:
      gt0015|30-day readmission risk: 16.4%
      gt0094|Mumtaz score: 2,1

- id: Total score 1
  input:
    1:
      gt0004|Primary payer: 0|local::at0009|Private insurance|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 0|local::at0039|Routine|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 4|local::at0006|40-65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 15.7%
      gt0094|Mumtaz score: 1,1

- id: Total score 0
  input:
    1:
      gt0004|Primary payer: 0|local::at0009|Private insurance|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 0|local::at0039|Routine|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 4|local::at0006|40-65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 15.1%
      gt0094|Mumtaz score: 0,1

- id: Total score -1
  input:
    1:
      gt0004|Primary payer: -1|local::at0012|No change or other|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 0|local::at0039|Routine|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 4|local::at0006|40-65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 14.5%
      gt0094|Mumtaz score: -1,1

- id: Total score -2
  input:
    1:
      gt0004|Primary payer: -3|local::at0010|Self-pay|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 0|local::at0039|Routine|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 4|local::at0006|40-65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 13.9%
      gt0094|Mumtaz score: -2,1

- id: Total score -3
  input:
    1:
      gt0004|Primary payer: -3|local::at0010|Self-pay|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 0|local::at0039|Routine|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 4|local::at0006|40-65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 13.3%
      gt0094|Mumtaz score: -3,1

- id: Total score -4
  input:
    1:
      gt0004|Primary payer: -3|local::at0010|Self-pay|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: -1|local::at0040|Transfer|
      gt0019|Hepatocellular carcinoma: 3|local::at0019|Yes|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 0|local::at0005|≥65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 12.7%
      gt0094|Mumtaz score: -4,1

- id: Total score -5
  input:
    1:
      gt0004|Primary payer: -1|local::at0012|No change or other|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: -1|local::at0040|Transfer|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 4|local::at0019|Yes|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 0|local::at0005|≥65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 12.2%
      gt0094|Mumtaz score: -5,1

- id: Total score -6
  input:
    1:
      gt0004|Primary payer: -3|local::at0010|Self-pay|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 0|local::at0039|Routine|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 4|local::at0006|40-65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 11.6%
      gt0094|Mumtaz score: -6,1

- id: Total score -7
  input:
    1:
      gt0004|Primary payer: -3|local::at0010|Self-pay|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 1|local::at0041|Home health care|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 0|local::at0005|≥65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 11.1%
      gt0094|Mumtaz score: -7,1

- id: Total score -8
  input:
    1:
      gt0004|Primary payer: -3|local::at0010|Self-pay|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 0|local::at0039|Routine|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 0|local::at0005|≥65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 10.6%
      gt0094|Mumtaz score: -8,1

- id: Total score -9
  input:
    1:
      gt0004|Primary payer: -3|local::at0010|Self-pay|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 2|local::at0019|Yes|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: -1|local::at0040|Transfer|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 0|local::at0005|≥65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 10.2%
      gt0094|Mumtaz score: -9,1

- id: Total score -10
  input:
    1:
      gt0004|Primary payer: -3|local::at0010|Self-pay|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: 0|local::at0039|Routine|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 0|local::at0005|≥65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 9.7%
      gt0094|Mumtaz score: -10,1

- id: Total score -11
  input:
    1:
      gt0004|Primary payer: -3|local::at0010|Self-pay|
      gt0005|Elixhauser Comorbidity Index: 0|local::at0015|<3|
      gt0006|Non-alcoholic etiology of cirrhosis: 0|local::at0018|No|
      gt0007|Ascites: 0|local::at0018|No|
      gt0008|Hepatic encephalopathy: 0|local::at0018|No|
      gt0009|Variceal bleeding: -7|local::at0019|Yes|
      gt0018|Disposition: -1|local::at0040|Transfer|
      gt0019|Hepatocellular carcinoma: 0|local::at0018|No|
      gt0020|Paracentesis during admission: 0|local::at0018|No|
      gt0021|Hemodialysis during admission: 0|local::at0036|No|
      gt0031|Age, years: 0|local::at0005|≥65|
  expected_output:
    1:
      gt0015|30-day readmission risk: 9.3%
      gt0094|Mumtaz score: -11,1
